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Abstract
Mitotic death is a delayed response of p53 mutant tumours that are resistant to genotoxic damage.
Questions surround why this response is so delayed and how its mechanisms serve a survival
function. After uncoupling apoptosis from G1 and S phase arrests and adapting these checkpoints,
p53 mutated tumour cells arrive at the G2 compartment where decisions regarding survival and
death are made. Missed or insufficient DNA repair in G1 and S phases after severe genotoxic
damage results in cells arriving in G2 with an accumulation of point mutations and chromosome
breaks. Double strand breaks can be repaired by homologous recombination during G2 arrest.
However, cells with excessive chromosome lesions either directly bypass the G2/M checkpoint,
starting endocycles from G2 arrest, or are subsequently detected by the spindle checkpoint and
present with the features of mitotic death. These complex features include apoptosis from
metaphase and mitosis restitution, the latter of which can also facilitate transient endocycles,
producing endopolyploid cells. The ability of cells to initiate endocycles during G2 arrest and
mitosis restitution most likely reflects their similar molecular environments, with down-regulated
mitosis promoting factor activity. Resulting endocycling cells have the ability to repair damaged
DNA, and although mostly reproductively dead, in some cases give rise to mitotic progeny. We
conclude that the features of mitotic death do not simply represent aberrations of dying cells but
are indicative of a switch to amitotic modes of cell survival that may provide additional mechanisms
of genotoxic resistance.
Introduction
Following severe genotoxic damage, cells undergo either
rapid or delayed death termed by Okada [1] as interphase
and reproductive deaths, respectively. Sensitive cells un-
dergo death within a few hours of genotoxic insult (if the
damage is not so enormous as to cause immediate necro-
sis), whilst damage resistant cells execute death after a
delay, precipitating either from the initial G2 arrest or af-
ter a number of cell divisions. In lymphoid and myeloid
cell lines, all three types of cell death require new protein
synthesis and exhibit the DNA ladder characteristic of
apoptosis [2].
This delayed reproductive death, also known as "mitotic
death", is characteristic of many p53 mutated tumours
that are resistant to genotoxic insult [3,4,5]. The main
features of mitotic death have been described by several
workers [6,7,8]. They include (a) the absence/delay of
the G1/S checkpoint and hence (b) the absence of inter-
phase apoptosis coupled to this checkpoint; (c) delay in
the G2 compartment followed by its adaptation and
hence (d) a sequence of aberrant mitoses which end in
mitotic death; (e) formation and disintegration of (multi-
nuclear) giant cells (which is often also termed mitotic
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death or catastrophe); (f) delayed apoptosis; and (g) fi-
nally survival.
Given this elaborate sequence of events associated with
resistance to genotoxic insult and poor oncological prog-
nosis [9], it is logical to suggest that these phenomena
may contribute to cell survival. To assess this possibility,
we must first explore the various facets of mitotic death.
Uncoupling of apoptosis
Terminal cell death ends any potential for repair or prop-
agation of a cell population and so the earlier death oc-
curs in the cell cycle following damage, the smaller the
potential for possible cell survival. From studies of p53,
the concept that there is a temporal element to the adap-
tive response of the cell to damage has emerged, and it
has been suggested that there is a "race between repair
and cell death" [10]. Therefore, it is clear that to ensure
genomic integrity, apoptosis should be tightly coupled to
cell cycle checkpoints and initiated rapidly [11,12]. For
this reason, apoptosis is mostly precipitated from the
G1/S checkpoint in normal, healthy, p53 wild-type cells
before segregation of genomes occurs, preventing any
chance of potentiating or fixing the damage later in the
cell cycle. As such, maintaining genome fidelity puts a
tight limit on the proliferative and survival capacity of
cells. Conversely, uncoupling cell death from cell cycle
checkpoints and delaying the terminal effector stage of
apoptosis should give cells a greater chance for repair, di-
versification of pathways and survival. This latter situa-
tion is observed in resistant tumours, where G1/S and S-
phase checkpoints fail [13] and where mitotic death is in-
itiated only at the last stage of the cell cycle, as the term
suggests, around the final stages of mitosis. The tight
negative correlation between delayed apoptosis and re-
lease from G2 arrest in p53 mutant tumours after irradi-
ation (Cragg et al., submitted), and other data [7,14,15]
suggest that the main decision for death versus survival
originates from the G2/M checkpoint. Thus, reaching the
G2 compartment would appear crucial for cell survival
and removing preceding checkpoints should increase re-
sistance. Importantly however, these resistant cells have
missed the chance of repair in G1 and S.
Repair of DNA strand-breaks
To repair damaged DNA, the damage must first be
sensed. The precise mechanisms for this are not yet
clear, although some current data suggests that p53 itself
[16] and repair proteins of the Rad 9 and Ku group, also
function as damage sensors [4,17]. Recent evidence also
indicates that in S-phase, sensing and repair of strand-
breaks competes with continued DNA replication.
Therefore, it may be that in resistant tumour cells, dam-
age is not repaired because it not sensed [18]. In support
of this notion, comparing S-phase delay for a panel of
lymphoid cell lines after a single dose of irradiation, the
most radioresistant cells delay least in S-phase and ex-
hibit the most extensive chromosomal aberrations
(Cragg et al; submitted). This situation is exacerbated by
the fact that conversion of single-strand breaks (SSB)
into pernicious double-strand breaks (DSB) and the er-
ror-prone trans-lesion DNA synthesis, are probably oc-
curring in this environment [4,19]. It is paradoxical then,
that unlike p53 mutated cells, p53 wild-type cells which
sense DNA damage and delay for repair in G1 and S, do
not recover from large genotoxic insults [20].
Potentially lethal DSB are repaired by non-homologous
end-joining (NHEJ) in G1/early S and by homologous re-
combination (HR), in late S/G2 [18,21]. NHEJ is by def-
inition error-prone and so error-free repair is only
possible through HR. Reaching the G2 compartment
provides the best chance for error-free DNA repair with-
in the mitotic cycle.
Delay in G2 – a rescue compartment?
Cells with DSB arrest in G2 at the G2/M DNA damage
checkpoint [22] and attempt HR. In fact, it was only re-
cently discovered that HR acts in human cells [18,23].
This HR repair capacity seems to be many-fold more ac-
tive in p53-mutated tumours than in wild-type counter-
parts [24] and therefore, G2 arrest should be considered
an important rescue compartment for damage-resistant
tumours. In support of this, the ability of various tumour
cell lines to accumulate after damage in G2 seems pro-
portional to their clonogenicity (Cragg et al., submitted)
and resistance to multiple anticancer drugs [14], whilst
abrogation of G2-arrest potentiates cell death [15]. This
type of response, providing maximal accumulation of
cells in G2, is due to loss of functional p53 [3,13,25] and
perhaps explains why mutations in p53 are selected for
during tumour progression.
Although possibly elevated in p53-mutated tumours, it is
clear that the repair capacity of the G2 compartment can-
not be limitless. If the damage is too extensive and the
cells have overcome (adapted) the G2/M checkpoint, the
mitoses that ensue are aberrant due to the genome insta-
bility and chromosome breaks. In addition, the ability of
chromosomes to stick at breakage sites is often displayed
in sequential post-damage mitoses as "bridge-break-fu-
sion" events and it is mostly this process which accounts
for a large proportion of first aberrant and then lethal
mitoses. All of these facets are due to secondary DNA
damage events and represent the "cost" of reaching the
G2 compartment. Several investigators have now shown
that secondary chromosome lesions and mis-repair di-
rectly cause chromosome breaks and evoke "mitotic ca-
tastrophe" [2,26,27,28,29].Cancer Cell International 2001, 1:1 http://www.cancerci.com/content/1/1/1
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Mitotic catastrophe
There are very diverse descriptions of mitotic catastro-
phe. Initially, mitotic catastrophe was associated with in-
complete DNA synthesis and premature chromosome
condensation [30,31], with features in common with ap-
optosis. Other authors define it as an aberrant form of
mitosis associated with the formation of multinucleate
giant cells that are temporarily viable but reproductively
dead [11,32]. Still others state that mitotic catastrophe is
pre-determined in G2 and characterised by an abortive
short cut into metaphase arrest [33,34]. Mitotic failure
often manifests with micronucleation [35,36] and nucle-
ar segmentation [37] and this in turn, is associated with
mitosis restitution into interphase polyploid cells [38].
An apoptosis-like, TUNEL-positive death from met-
aphase-arrest can often be observed in tumours after
various apoptogens [37]. It frequently accompanies mi-
tosis restitution [39], and is commonly seen during the
development of micronuclei and nuclear segments,
which are themselves initially TUNEL-negative [40,41].
Clearly, the features of mitotic catastrophe are eclectic
[39]. In fact, although these events are usually viewed as
deviations from the normal cell cycle, they involve phe-
nomena that are not necessarily associated with mitosis,
such as micronucleation, restitution, and polyploidy. In-
deed, the last of these is clearly associated with the endo-
cycle, and we would suggest that initiating the endocycle
provides an alternative to mitotic catastrophe in resist-
ant cells.
Endopolyploid giant cells
Polygenomic giant cells can arise from G2 arrested cells
[7,42,43], by cell fusion or by mitotic restitution
[38,44,45]. In all cases, tetraploidy appears to be a pre-
requisite for initiation of endocycles. True endopoly-
ploids contain several chromosome sets and are usually
formed in a series of restitution cycles by (polyploidis-
ing) mitoses, which are aborted after segregation of sis-
ter chromatids. These cells are thought to be able to
return to the diploid state either through mitosis omit-
ting S-phases or by multipolar mitosis [46]. Interesting-
ly, studies on human megakaryocytes in culture [47]
showed that 8N-16N giant nuclei express cyclin B1 and
that this co-precipitates with H1 histone kinase activity.
Thus, these nuclei retain competency for mitosis and
subsequently, multipolar mitoses with centrosomes co-
localized with cyclin B follow. For the S-phase 16N-32N
cells and for 32N and 64N cells, these activities are
strongly reduced. These data are in line with numerous
reports that 8N-ploidy represents a general limit, above
which cells cannot execute mitosis. 16N-32N cells and
cells of higher ploidy are usually unable to divide by mi-
tosis, and therefore belong to the so-called hyperploid
class of polyploids [44].
Hyperploidy, which can reach very high DNA content
values, is widely observed during the development of
transient organs in animals and plants [44,46,48]. Un-
like in true endopolyploids, in hyperploid cells, sister
chromatids usually do not become separated after repli-
cation rounds [44,46,48] and especially if slightly con-
densed, retain partial cohesion at highly reiterated sites.
Most likely, such a polytenic kind of endopolyploidy aris-
es initially from cells arrested in the G2/M or spindle
checkpoint and renders these nuclei unable to segregate
chromosomes by mitosis.
Although mostly reproductively dead, these cells howev-
er, can also return to the diploid state, through a specific
kind of cell division termed de-polyploidisation, which
involves de-polytenization, somatic pairing of homologs
and subsequent reduction divisions [44]. Such a process,
termed also "meiosis without karyogamy", has been de-
scribed by Grell in Culex [49] and in the asexual life-cycle
of Radiolaria, reviewed in [50]. Although somatic reduc-
tion is likely to occur in higher plants, the possibility of a
similar process occurring in mammalian cells remained
until recently only speculation [42,44].
In malignant tumours, there is often a population of cells
with a DNA content above the diploid value of the so-
called stem-line and in many cases a number of high-
ploidy cells are evident [51]. The proliferative potential of
this latter population remains controversial. Some au-
thors claim that high ploidy cells have reduced prolifera-
tive potential [52] or even none at all [53,54]. Others
have found that although these cells are usually delayed
in, and often deleted from, metaphase, they can prolifer-
ate either normally [55] or through multipolar mitoses
[56], although these observations may refer only to oli-
goploid tumour cells. We have observed giant cells of
8N-128N and more, as a transient response of p53 mu-
tated human lymphoma cell lines to genotoxic damage or
spindle poisons. Within this response, some endopoly-
ploid cells appear to undergo somatic reduction and/or
multipolar mitoses and produce mitotic descendants
[[41,57], also unpublished]. Therefore, it is important to
consider how endopolyploids originate from, and return
to, the mitotic cycle, with respect to the different molec-
ular environments required.
Molecular machinery of the endocycle
The mitotic cycle is dependent upon the action of the mi-
tosis-promoting factor (MPF), which is a complex of cy-
clin B and cdc2 kinase (p34 cdk1). The MPF
phosphorylates various substrates including MAPs, lam-
ins, and histone HI, which subsequently induce the spin-
dle assembly, breakdown of nuclear envelope, and
chromosome condensation, necessary for mitosis. In
contrast, lack of MPF activity and inability to execute mi-Cancer Cell International 2001, 1:1 http://www.cancerci.com/content/1/1/1
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tosis is considered a hallmark of the endocycle [8,42,58].
A recent study of reprogramming the cell cycle for en-
doreduplication in rodent trophoblast cells has shown
that the arrest of the mitotic cycle at the onset of endore-
duplication was associated with a failure to assemble the
MPF [59], at the G2/M checkpoint. The same can be
achieved by inhibiting cdc2 activity with the kinase in-
hibitor, staurosporine [45]. The main component of MPF
inactivity appears to be lack of nuclear cyclin B1 localisa-
tion in the endocycle [8].
For endoreduplication, DNA synthesis must occur inde-
pendently of mitosis and for this to happen several
checkpoints must be overcome. These checkpoints are
located in late S-phase (S/M [34], telophase [60], centro-
some duplication [61] checkpoints), in G2-phase (G2/M
checkpoint [22], and in M-phase (spindle and post-spin-
dle checkpoints [62,63]). In the endoreduplication cycle,
cells shuttle only between G1 and S-phase, with a trun-
cated late S-phase [8,42,44,64] and therefore many of
these checkpoints are naturally absent, allowing un-
checked DNA synthesis.
The MPF also negatively regulates the assembly of the
replication complex [8]. Stable overexpression of cyclin
E, which is part of the replication complex and the main
driver of replication, is a characteristic feature of endocy-
cling and tumour cells [8,58,60,64,65]. Therefore, it
seems likely that when DNA synthesis becomes unsched-
uled, due to the inactivity of the anaphase promoting
complex APC and the post-spindle replication check-
point, this stable and abundant cyclin E down-regulates
cdc2 kinase, and thus renders the MPF inactive, enabling
decondensation of chromosomes and reset of inter-
phase.
Most of the checkpoints detailed above are p53 depend-
ent, and so not surprisingly, the ability to initiate endo-
cycles and form endopolyploid cells is characteristic of
cells lacking wild-type p53 function [15,43,66].
Influence of DNA damage
Genotoxic damage in particular enhances this transition
from the mitotic cycle into the endocycle in p53 mutant
cells [15,66]. The arrest in the G2/M checkpoint is
known to activate chk1, which induces the phosphoryla-
tion of cdc25. This results in cdc2 remaining phosphor-
ylated on Tyr 15, causing its inactivation and through the
subsequent molecular pathway, retaining the cytoplas-
mic localisation (nuclear export) of cyclin B1 [22]. Con-
sequently, DNA damage, causing G2 arrest and
preventing MPF assembly, may provide the necessary
molecular environment to trigger entry into the endocy-
cle instead of mitosis.
Another molecular constraint to overcome, to allow en-
doreduplication, concerns the APC which couples mito-
sis to a new round of DNA replication. This function is
performed by the targeted proteolysis of several sub-
strates necessary for the completion of mitosis [62]. Ar-
rest at the spindle checkpoint caused by post-damage
secondary DNA breaks or by spindle damage, down-reg-
ulates APC activity, thus preventing exit from mitosis but
allowing entry into the endocycle by the pathways de-
tailed above [8] and in [67].
In summary, the characteristic features of p53 mutated
cancer cells in conjunction with DNA damage, appears to
facilitate the molecular environment necessary to pro-
vide a shift from mitosis into the endocycle. The main
switch-points for these transitions are outlined on Figure
1, although it should be mentioned that apoptosis repre-
sents another, third option.
Our own studies (Cragg et al., submitted) have shown
that in p53-mutated cells, the radiation dose threshold
for entering the endocycle from damage induced G2 ar-
rest is higher than for entering mitosis, and in particular,
in more resistant cells i.e. cells can still enter the endocy-
cle after high doses of irradiation. One possible explana-
tion for these data is that the endocycle provides a
survival advantage.
Can giant cells repair DNA?
If giant cells do provide a survival advantage after geno-
toxic insult, then presumably they must be able to repair
DNA. In support of this suggestion, chromatid exchang-
es have been found between sister chromatids in the en-
dopolyploid nuclei of rodent fibroblasts [68,69].
Importantly, crossing over at each site appears only to
occur between two of the many aligned chromonemes on
the multichromonemic chromosomes [70] potentially al-
lowing the production of a fully repaired chromosome.
Furthermore, some data suggest that homologous chro-
mosomes, which are randomly distributed in the mitotic
cycle of diploid cells [71], become relocated and paired in
polyploids [70,72]. This early data has acquired some re-
cent support [73] as it has been shown that homologous
chromosomes come together in generative polyploids
long before meiosis begins.
In endopolyploid tumour cells, for recombination and
somatic reduction to happen, reorganisation of endopol-
yploid nuclei should occur to provide pairing of homolo-
gous chromosomes. In support of this suggestion, a
complex somatic reduction process involving meiotic-
like bouquets has been reported recently by our group for
some Burkitt's lymphoma cell lines after high doses of ir-
radiation [41,59].Cancer Cell International 2001, 1:1 http://www.cancerci.com/content/1/1/1
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Although initially this process appears extremely exotic,
it has serious molecular and evolutionary grounds. An
attractive idea linking meiotic recombination with DNA
repair in somatic cells was recently proposed by Kleckner
[74] who suggested that crossing over and meiosis both
originated during evolution from the necessity to repair
DNA double strand breaks in the mitotic cycle. Further-
more, the molecular relationship between meiotic re-
combination and the mitotic DNA damage checkpoints
has now been established [75]. In addition, it is worth-
while to note that the endocycle is probably more ancient
than both meiosis and mitosis in evolution [76] and that
somatic reduction introduces elements of meiosis into
endopolyploid cells. This latter may be important, as re-
combination DNA repair by exchange between homologs
in meiosis has been reported to be up to 10 times more
effective than between sister chromatids [77].
Somatic reduction of endopolyploid cells, including pair-
ing of homologs similar to that in meiosis, may therefore
represent an effective means of both DNA repair and re-
turn to diploidy and the mitotic cycle. In fact, comparing
the efficacy of HR in different cell cycle compartments
reported in the literature, it can be inferred that HR effi-
ciency increases from G1 to G2 [78] and then still further
from G2 of the mitotic cycle to the endocycle. Possibly
therefore, in the race between DNA repair and apoptosis,
repair is elevated and apoptosis delayed further and fur-
Figure 1
The schema shows the available switchpoints from the mitotic pathway to the endocycle in p53 mutant cells and stimulation of
this switch by DNA damage. As can be seen, G2 arrested cells can go directly from the G2/M damage checkpoint into the
endocycle or go on to apoptose. However, if the G2/M checkpoint is adapted, cells can also enter into mitosis, and from there
possible arrest in metaphase. In turn, M-arrest has three alternative exits: to return to the mitotic cycle, to undergo apoptosis
or, through restitution, to enter the endocycle. Mitosis restitution is unstable and can be aborted evoking apoptosis. Endocy-
cling cells often precipitate apoptosis, but can also return through somatic reduction to the mitotic cycle. The checkpoint(s) for
this last process is unknown.Cancer Cell International 2001, 1:1 http://www.cancerci.com/content/1/1/1
Page 6 of 7
(page number not for citation purposes)
ther, allowing this extreme shift into the endocycle to oc-
cur in the most resistant tumours.
Conclusion
In conclusion, after extensive DNA damage, p53 mutated
cells miss DNA repair and apoptosis at the G1 and S
phase checkpoints and accumulate at the G2 arrest com-
partment with point mutations and chromosome breaks.
The latter exhibit at the spindle checkpoint with mitotic
catastrophe. In the absence of p53, the various phenom-
ena of mitotic death, including mitosis restitution, are
induced in an attempt to execute an evolutionarily con-
served survival program via transient endocycles. The
molecular environment of G2 arrest and restituting mi-
tosis down-regulates MPF activity allowing initiation of
the endocycle. The resulting polyploid cells may harbour
greater DNA repair capacity coupled with the potential
to return to the mitotic cycle and may therefore provide
a survival advantage.
References
1. Okada S: Radiation Biochemistry (Eds: Altman KI, Gerber GB and
Okada S), Vol.1, Academic Press, New York 1970
2. Radford IR, Murphy TK: Radiation response of mouse lymphoid
and myeloid cell lines. Part III. Different signals can lead to
apoptosis and may influence sensitivity to killing by DNA
double-strand breakage. Int J Radiat Biol 1994, 65:229-239
3. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science
1994, 266:1821-1828
4. Friedberg EC: DNA repair and mutagenesis. (Eds: Friedberg EC,
Walker GS, Siede W) Washingtone, DC:ASM Press 1995
5. Zhivotovsky B, Bertrand J, Orrenius S: Tumour radiosensitivity
and apoptosis. Exp Cell Res 1999, 248:10-17
6. Lock RB, Ross WE: Possible Role for the p34cdc2 Kinase in
Etoposide-induced Cell Death of Chinese Hamster Ovary
Cells. Cancer Res 1990, 50:3767-3771
7. Bernhard EJ, Muschel RJ, Bakanauskas VJ, McKenna W: Reducing
the radiation-induced G2 delay causes HeLa cells to undergo
apoptosis instead of mitotic death. Int J Radiat Biol 1996, 69:575-
584
8. Grafi G: Cell cycle regulation of DNA replication. The en-
doreduplication perspective (minireview). Exp Cell Res 1998,
244:372-378
9. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I: Role of the
p53 tumor supressor gene in cell cycle arrest and radiosensi-
tivity of Burkitt's lymphoma cell lines.  Cancer Res 1993,
53:4776-4780
10. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Me-
tastasis Rev 1992, 11:121-139
11. King KL, Cidlowski JA: Cell cycle and apoptosis: common path-
ways to life and death. J Cell Biochem 1995, 58:175-180
12. Diffey JFX, Evan G: Oncogenes and cell proliferation. Cell cycle,
genome integrity, and cancer – millenial view. Curr Opin Genet
Dev 1993, 10:13-16
13. Paulovich AG, Toczysky DP, Hartwell LH: When checkpoints fail.
Cell 1997, 88:315-321
14. Bedi A, Barber JP, Bedi JC, El-Deiry WC, Sidransky D, Vala MS, Akhtar
AJ, Hilton J, Jones RJ: BCR-ABL-mediated inhibition of apopto-
sis with delay of G2-M transition after DNA damage: a mech-
anism of resistance to multiple anticancer agents. Blood 1995,
86:1148-1158
15. Bracey TS, Williams AC, Paraskeva C: Inhibition of radiation-in-
duced G2 delay potentiates cell death by apoptosis and/or
the induction of giant cells in colorectal tumour cells with
disrupted p53 function. Nature 1996, 381:713-716
16. Pfeifer GP, Holmquist GP: Mutagenesis in the P53 gene. Biochem
Biophys Acta 1997, 1333:M1-M8
17. Lowndes NF, Muguia JR: Sensing and responding to DNA dam-
age. Curr Opin Genet Dev 2000, 10:17-25
18. Karran P: DNA double strand break repair in mammalian
cells. Curr Opin Genet Dev 2000, 10:144-150
19. Goodman MF, Tippin B: Sloppier copier DNA polymerases in-
volved in genome repair. Curr Opin Genet Dev 2000, 10:162-168
20. Linke SP, Clarkin KC, Wahl GM: p53 mediates permanent arrest
over multiple cell cycles in response to gamma-irradiation.
Cancer Res 1997, 57:1171-1179
21. Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H,
Yamaguchi-Iwai Y, Shinohara A, Takeda S: Homologous recombi-
nation and non-homologous end-joining pathways of DNA
double-strand break repair have overlapping roles in the
maintenance of chromosomal integrity in vertebrate cells.
EMBO J 1998, 17:5497-5508
22. Weinert T: DNA damage checkpoint update: Getting molec-
ular. Curr Opin Genet Dev 1998, 8:185-193
23. Liang FM, Han M, Romanienko PJ, Jasin M: Homology-directed re-
pair is a major double-strand break repair pathway in mam-
malian cells. Proc Natl Acad Sci USA 1998, 95:5172-5177
24. Mekeel K, Tang W, Kachnic LA, Luo CM, DeFrank JS, Powell SN: In-
activation of p 53 results in high rates of homologous recom-
bination. Oncogene 1997, 14:1847-1857
25. Schwartz D, Rotter V: p53-dependant cell cycle control: re-
sponse to genotoxic stress. Semin Cancer Biol 1998, 8:325-336
26. Scott D, Fox M, Fox BW: The relationship between chromo-
somal aberrations, survival and DNA repair in tumour cell
lines of differential sensitivity to X-rays and sulphur mustard.
Mutat Res 1974, 22:207-221
27. Chadwick KH, Leenhouts HP: Radiation induced chromosome
aberrations: some biophysical considerations. Mutat Res 1998,
404:113-117
28. Bryant PE: The Signal Model: a possible explanation for the
conversion of DNA double-strand breaks into chromatid
breaks. Int J Radiat Biol 1998, 73:243-251
29. Rogers-Bald M, Sargent RG, Bryant PE: Production of chromatid
breaks by single dsb: Evidence supporting the signal model.
Int J Radiat Biol 2000, 76:23-29
30. Mackay MA, Morgan WF, Dewey WC: Nuclear fragmentation
and premature chromosome condensation induced by heat
shock in S-phase Chinese hamster ovary cells. Cancer Res 1988,
48:6478-6483
31. lanzini F, Mackay MA: Delayed DNA damage associated with
mitotic catastrophe following X-irradiation of HeLa S3 cells.
Mutagenesis 1998, 13:337-344
32. Miranda El, Santana C, Rojas E, Hernandez A, Ostrosky-Wegman P,
Garcia-Carranca A: Induced mitotic death of HeLa cells by ab-
normal expression of c-H-ras. Mutat Res 1996, 349:173-182
33. Kondo S: Apoptosis by antitumour agents and other factors in
relation to cell-cycle checkpoints.  J Radiat Res (Tokyo) 1995,
36:56-62
34. Rhind N, Russell P: Mitotic DNA damage and replication
checkpoints in yeast. Curr Opin Cell Biol 1998, 10:749-758
35. Heddle JA, Carrano AV: The DNA content of micronuclei in-
duced in mouse bone marrow by gamma-irradiation: evi-
dence that micronuclei arise from acentric chromosomal
fragments. Mutat Res 1977, 44:63-69
36. Abend M, Gilbertz K-P, Rhein A, van Beuningen D: Early and late
G2 arrest of cells undergoing radiation-induced apoptosis or
micronucleation. Cell Prolif 1996, 29:101-113
37. Dini L, Coppola S, Ruzittu MT, Ghibelli L: Multiple Pathways for
Apoptotic Nuclear Fragmentation. Exp Cell Res 1996, 223:340-
347
38. Nagl W: Polyploidy in differentiation and evolution. Int J Cell
Cloning 1990, 8:216-223
39. Erenpreisa Je, Ivanov A, Dekena G, Vitina A, Krampe R, Freivalds T,
Selivanova G, Roach Hl: Arrest in metaphase and anatomy of
mitotic catastrophe: mild heat shock in two human osteosa-
rcoma cell lines. Cell Biol Int 2000, 24:61-71
40. Shimizu N, Itoh N, Utiyama H, Wahl GM: Selective entrapment of
extrachromosomally amplified DNA by nuclear budding and
micronucleation during S-phase. J Cell Biol 1998, 140:1307-1320
41. Illidge TM, Cragg MS, Fringes B, Olive P, Erenpreisa JA: Polyploid gi-
ant cells provide a survival mechanism for p53 mutant cells
after DNA damage. Cell Biol Int 2000, 24:621-633Cancer Cell International 2001, 1:1 http://www.cancerci.com/content/1/1/1
Page 7 of 7
(page number not for citation purposes)
42. Nagl W: Cdc2-kinases, cyclins, and the switch from prolifera-
tion to polyploidization. Protoplasma 1995, 188:143-150
43. Waldman T, Lengauer C, Kinzler KW, Vogelstein B: Uncoupling of
S phase and mitosis induced by anticancer agents in cells
lacking p21. Nature 1996, 381:713-716
44. Nagl W: Endopolyploidy and polyteny in differentiation and
evolution. North-Holland Publ, Amsterdam-New York-Oxford 1978
45. Hall L, Th'ng JPH, Guo XW, Teplitz RL, Bradbury EM: A brief stau-
rosporine treatment of mitotic cells triggers premature exit
from mitosis and polyploid cell formation. Cancer Res 1996,
56:3551-3559
46. Brodsky VY, Uryvayeva IV: Genome multiplication in growth
and development. Cambridge University Press, 1985
47. Vitrat N, Cohen-Solal K, Pique C, Couedic J-P, Norol F, Larsen AK,
Katz A, Vaichenker W, Debili N: Endomitosis of human meg-
akaryocytes are due to abortive mitosis. Blood 1998, 91:3711-
3723
48. Zybina EV, Zybina TG: Polytene chromosomes in mammalian
cells. Int Rev Cytol 1996, 165:53-119
49. Grell M: Cytological studies in Culex. I Somatic reduction di-
vision. Genetics 1946, 31:60-70
50. Raikov IB: The protozoan nucleus. Morphology and evolution.
Springer Verlag, Wien-N.Y 1982
51. Bohm N, Sandritter W: DNA in human tumours: a cytophoto-
metric study. Curr Top Pathol 1975, 560:151-219
52. Gustavino B, Bassani B, Pacchierotti F: Vinblastine-induced nu-
merical chromosome changes and selection processes in
mouse bone marrow cells. Mutat Res 1991, 248:45-50
53. Frankfurt OS, Chin JL, Erglander LS, Greco WR, Pontes JE, Rustum
YM: Relationship between DNA ploidy, glandular differentia-
tion and tumour spread in human prostate cancer. Cancer Res
1985, 45:1418-1423
54. Therman E, Kuhn EM: Mitotic modifications and aberrations in
cancer. Crit Rev Oncog 1989, 1:293-305
55. Dooley WC, Allison DC, Robertson J: Discrepancies among the
metaphase, telophase, and the GO/G1 and G2 DNA peaks of
heteroploid cell lines. Cytometry 1991, 12:99-106
56. de la Hoz C, Baroja A: Proliferative behaviour of high-ploidy
cells in two murine tumour lines. J Cell Sci 1993, 104:31-36
57. Je Erenpreisa A, Cragg MS, Fringes B, Sharakhov I, Illidge TM: Release
of mitotic descendants from irradiated Burkitt's lymphoma
cell lines. Cell Biol Int 2000, 24:635-648
58. Grafi G, Larkins BA: Endoreduplication in maize endosperm:
Involvement of M-phase-promoting factor inhibition and in-
duction of S-phase related kinases. Science 1995, 269:1262-1264
59. MacAuley A, Cross JC, Werb Z: Reprogramming the cell cycle
for endoreduplication in rodent trophoblast cells. Mol Biol Cell
1998, 9:795-807
60. Price CM: Telomeres and telomerase: broad effect on cell
growth. Curr Opin Genet Dev 1999, 9:218-224
61. Winey M: Genome stability: Keeping the centrosome on
track. Curr Biol 1996, 6:962-964
62. Amon A: The spindle checkpoint. Curr Opin Genet Dev 1999, 9:67-
75
63. Lanni JS, Jacks T: Characterization of the p53-dependant post-
mitotic checkpoint following spindle disruption. Mol Cell Biol
1998, 18:1055-1064
64. Lilly MA, Spradling AC: The Drosophila endocycle is controlled
by cyclin E and lacks a checkpoint ensuring S-phase comple-
tion. Genes Dev 1996, 10:2514-2526
65. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677
66. Merrit AJ, Terence DA, Potten CHS, Hickman JA: Apoptosis in
small intestinal epithelia from p53-null mice: evidence for a
delayed, p53-independent G2/M-associated cell death after
irradiation. Oncogene 1997, 14:2759-2766
67. King RW, Deshaies RJ, Peters J-M, Kirschner MW: How proteolysis
drives the cell cycle. Science 1996, 274:1652-1659
68. Wandel KH: Spatial relationships in the replication of chro-
mosomal DNA. Genetics 1965, 51:915-929
69. Schwarzacher HG, W Schnedl: Position of labelled chromatids in
diplochromosomes of endo-reduplicated cells after uptake
of tritiated thymidine. Nature 1966, 209:107-108
70. Henderson SA: Chromosome pairing, chiasmata and crossin-
gover. In: Handbook of Molecular Cytology, Frontiers of Biology 15: North
Holand publishers, Amsterdam, 2969. Ed Lima-de-Faria 1969326-357
71. Inbar , Kupiec M: Homology search and choice of homologous
partner during mitotic recombination.  Mol Cell Biol 1999,
19:4134-4142
72. White MJD: Animal cytology and evolution. 3rd ed., Cambridge
University press, 1973
73. Martinez-Perez E, Shaw P, Moore G: The PH1 locus is needed to
ensure specific somatic and meiotic centromere association.
Nature 2001, 411:204-207
74. Kleckner N: Meiosis: How could it work? Proc Natl Acad Sci USA
1996, 93:8167-8174
75. Page AW, Orr-Weaver TL: Stopping and starting the meiotic
cell cycle. Curr Opin Genet Dev 1997, 7:23-31
76. Kondrashov AS: The asexual ploidy cycle and the origin of sex.
Nature 1994, 370:213-216
77. Petes TD, Pukkila PJ: Meiotic sister chromatid recombination.
Adv Genet 1995, 33:41-62
78. Kadyk LC, Hartwell LH: Sister chromatids are preferred over
homologs as substrates for recombination repair in Saccha-
romyces cerevisae. Genetics 1992, 132:387-402
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com